scispace - formally typeset
A

Addanki P. Kumar

Researcher at University of Texas Health Science Center at San Antonio

Publications -  79
Citations -  7833

Addanki P. Kumar is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 30, co-authored 73 publications receiving 7093 citations. Previous affiliations of Addanki P. Kumar include University of Texas MD Anderson Cancer Center & University of Colorado Boulder.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.

Chun Liang Chen, +12 more
- 01 Jun 2013 - 
TL;DR: It is postulate that CTCs expressing genes related to epithelial–mesenchymal transition (EMT) are strong predictors of metastatic prostate cancer.
Journal ArticleDOI

Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity

Rita Ghosh, +5 more
- 18 Feb 2005 - 
TL;DR: Examination of the mechanism of the antiproliferative action of eugenol in the human malignant melanoma cell line, WM1205Lu, showed that it arrests cells in the S phase of the cell cycle, suggesting that eugenols could be developed as an E2F-targeted agent for melanoma treatment.
Journal ArticleDOI

Regulation of BRCA1 expression by the Rb-E2F pathway.

Aijin Wang, +4 more
- 11 Feb 2000 - 
TL;DR: It is demonstrated that the product of the RB1 gene, Rb, regulates the expression of the murine Brca1 and human BRCA1 genes through its ability to modulate E2F transcriptional activity.
Journal ArticleDOI

CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy.

Shujie Zhao, +8 more
- 15 Nov 2016 - 
TL;DR: PDAC cells expressing high levels of CD44s with a mesenchymal-like phenotype were highly invasive and developed gemcitabine resistance in vivo, suggesting initial targeting CD44 or reversing the CD44high phenotype may improve therapeutic response.